A Medical Device Daily

etrials Worldwide (Morrisville, North Carolina) and Datasci (Malvern, Pennsylvania) reported that the companies have settled their pending litigation related to Datasci's U.S. patent concerning the collection and validation of clinical trial data.

etrials said that it entered into a non-exclusive licensing arrangement and agreed to pay Datasci $1.75 million as an upfront license fee for its legacy EDC products ASFlash, QSCapture and WebCapture.

In return, Datasci has agreed to dismiss its claims with prejudice and acknowledges that etrials' current EDC 2.0 product is not subject to any future royalty obligations.

Chip Jennings, president/CEO of etrials, said "We believe this agreement to be in the best interest of the company and its shareholders. The settlement limits any future exposure and allows us to focus all of our attention on improving etrials' core operations and expanding our market share within the rapidly growing market for eClinical technologies and services."

etrials provides eClinical software and services to pharmaceutical, biotech, medical device, and contract research organizations offers insight into clinical trials. offer electronic data capture, interactive voice response, and electronic patient diaries as part of an integrated software as a service platform or as individual solutions to optimize clinical trials.

No Comments